Vol 2, No 3 (June 27, 2013): Translational Lung Cancer Research (Lung Cancer Issue-Guest Editors: Rafael Rosell, Niki Karachaliou)

Review Articles

Adaptive resistance to targeted therapies in cancer
Rafael Rosell, Niki Karachaliou, Daniela Morales-Espinosa, Carlota Costa, Miguel Angel Molina, Irene Sansano, Amaya Gasco, Santiago Viteri, Bartomeu Massuti, Jia Wei, María González Cao, Alejandro Martínez Bueno
Translational Lung Cancer Research  
2013;
2
(3)
:152-159
.
 (27 May 2013) 
PDF Full Text (9429) Open Access Get Permission
Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)
Laura Bonanno
Translational Lung Cancer Research  
2013;
2
(3)
:160-171
.
 (27 May 2013) 
PDF Full Text (5191) Open Access Get Permission
The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
Niki Karachaliou, Rafael Rosell, Santiago Viteri
Translational Lung Cancer Research  
2013;
2
(3)
:172-179
.
 (27 May 2013) 
PDF Full Text (8908) Open Access Get Permission
Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
Jia Wei, Teresa Moran, Zhengyun Zou, Xiaoping Qian, Lifeng Wang, Carlos Camps, Wenjing Hu, Imane Chaib, Belén Sanchez, Lixia Xu, Niki Karachaliou, María Sanchez-Ronco, Baorui Liu, Rafael Rosell
Translational Lung Cancer Research  
2013;
2
(3)
:180-188
.
 (27 May 2013) 
PDF Full Text (5531) Open Access Get Permission
State of the art of radiotherapy
Pilar Garrido, Mª Eugenia Olmedo
Translational Lung Cancer Research  
2013;
2
(3)
:189-199
.
 (27 May 2013) 
PDF Full Text (6061) Open Access Get Permission
Management of elderly patients
Alain Vergnenegre, Romain Corre, Hervé Lena, Hervé Le Caer
Translational Lung Cancer Research  
2013;
2
(3)
:200-207
.
 (27 May 2013) 
PDF Full Text (5974) Open Access Get Permission
Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?
Bartomeu Massuti, Jose Miguel Sanchez, Florentino Hernando-Trancho, Niki Karachaliou, Rafael Rosell
Translational Lung Cancer Research  
2013;
2
(3)
:208-221
.
 (27 May 2013) 
PDF Full Text (6676) Open Access Get Permission
International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature
Johannes R. Kratz, Michael J. Mann, David M. Jablons
Translational Lung Cancer Research  
2013;
2
(3)
:222-225
.
 (27 May 2013) 
PDF Full Text (2820) Open Access Get Permission
Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients
Margarita Majem, Jordi Remon
Translational Lung Cancer Research  
2013;
2
(3)
:226-237
.
 (27 May 2013) 
PDF Full Text (4489) Open Access Get Permission
Apoptotic agents
Dean A. Fennell
Translational Lung Cancer Research  
2013;
2
(3)
:238-243
.
 (27 May 2013) 
PDF Full Text (6018) Open Access Get Permission
BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors
José Miguel Sánchez-Torres, Santiago Viteri, Miguel Angel Molina, Rafael Rosell
Translational Lung Cancer Research  
2013;
2
(3)
:244-250
.
 (27 May 2013) 
PDF Full Text (10126) Open Access Get Permission
EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner
Translational Lung Cancer Research  
2013;
2
(3)
:251-255
.
 (27 May 2013) 
PDF Full Text (6980) Open Access Get Permission

Disclosure:

The focused issue “Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Rafael Rosell and Niki Karachaliou served as the unpaid Guest Editors for the focused issue.